NASDAQ:AIXC Qualigen Therapeutics Q4 2025 Earnings Report $0.79 -0.03 (-3.98%) As of 04:00 PM Eastern ProfileEarnings HistoryForecast Qualigen Therapeutics EPS ResultsActual EPS-$3.76Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AQualigen Therapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AQualigen Therapeutics Announcement DetailsQuarterQ4 2025Date3/30/2026TimeBefore Market OpensConference Call DateMonday, March 30, 2026Conference Call Time8:00AM ETConference Call ResourcesAnnual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsAnnual report(10-K) Qualigen Therapeutics Earnings HeadlinesAIXC targets August 2026 RoboShare rentals in Los Angeles as liquidity remains constrainedAugust 8 at 7:04 PM | seekingalpha.comAIxCrypto Holdings, Inc. (AIXC) Q2 2026 Earnings Call TranscriptAugust 7 at 11:00 PM | seekingalpha.comThe ultimate IPO unicornAnthropic is now worth more than a trillion dollars, making it the first private company to reach that milestone. Its valuation exceeds every American airline combined and even tops the U.S. defense budget. The company's annualized revenue grew 80 times over in the first quarter alone. Anthropic has already filed IPO paperwork, with some estimates pointing to a public debut as early as October.August 10 at 1:00 AM | Weiss Ratings (Ad)AIxCrypto Holdings Reports Second Quarter 2026 ResultsAugust 7 at 5:37 PM | prnewswire.comQualigen Therapeutics (NASDAQ:AIXC) Shares Down 3.4% - Time to Sell?August 6, 2026 | americanbankingnews.comAIxCrypto Announces Second Quarter 2026 Earnings Conference Call DetailsAugust 4, 2026 | prnewswire.comSee More Qualigen Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Qualigen Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Qualigen Therapeutics and other key companies, straight to your email. Email Address About Qualigen TherapeuticsQualigen Therapeutics (NASDAQ:AIXC), a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.View Qualigen Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat5 Stocks the Market Rewarded After Strong Earnings ResultsQuantum Earnings Week: Winners and Losers Are Finally EmergingMarketBeat Week in Review – 08/03 - 08/07Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of WarCloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in FocusIs Monster Beverage’s Best-Case Scenario Already Priced Into the Stock? Upcoming Earnings SEA (8/11/2026)Cardinal Health (8/11/2026)Lumentum (8/11/2026)Cisco Systems (8/12/2026)Brookfield (8/13/2026)NU (8/13/2026)Applied Materials (8/13/2026)BHP Group (8/17/2026)Palo Alto Networks (8/17/2026)Home Depot (8/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
